Urokinase I believe that you must have understood through the previous
introduction, today I would like to introduce to you the injection of
recombinant human urokinase pro-busy drugs mainly suitable for acute ST-segment
elevation myocardial infarction, it is a kind of colorless transparent fluid, so
what should we pay attention to when it is used? Next, follow Xiaobian together
to understand it.
With urokinase of restructuring the original when use as well as other
thrombolytic drugs, and drug use to weigh the expected treatment effect and the
possible danger, for example, intracranial hemorrhage in the elderly patients
with increased risk, and elderly patients benefit will increase, therefore to
weigh the pros and cons, mentioned the bleeding tendency, in the
contraindications for injection restructuring the dosage of urokinase was no
more than 50 mg, Otherwise, there is an increased risk of intracranial bleeding.
In addition, experience with reuse is limited. The following tests are
recommended before use, such as clotting time, prothrombin time, and activated
partial thromboplastin time.
This is how much attention should be paid to the use of recombinant human
prourokinase for injection. Please continue to pay attention to more relevant